Stimulus amplification, efficacy, and the operational model. Part II - Ternary complex occupancy mechanisms

Journal of Theoretical Biology

Volumn 198, Issue 3, 1999, Pages 347-374

  Trzeciakowski, J P ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; DRUG RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; COMPLEX FORMATION; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; DRUG RESPONSE; MATHEMATICAL MODEL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

EID: 0033532568     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1999.0920     Document Type: Article

References (46)

1. Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P. & Clarke, W. P. (1998). Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54, 94-104.
2. Berman, D. M. & Gilman, A. G. (1998). Mammalian RGS proteins: Barbarians at the gate. J. Biol. Chem. 273, 1269-1272.
3. Black, J. W. & Leff, P. (1983). Operational models of pharmacological agonism. Proc. R. Soc. B. 220, 141-162.
4. Black, J. W., Leff, P., Shankley, N. P. & Wood, J. (1985). An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol. 84, 561-571.
5. Burstein, E. S., Spalding, T. A. & Brann, M. R. (1997). Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins. J. Pharmacol. Exp. Ther. 51, 312-319.
6. Clark, A. J. (1937). General pharmacology. In: Heffner's Handbuch der Experimentellen Pharmakologie Erganzungswerk Band 4. Berlin: Springer-Verlag.
7. Clarke, W. P. & Bond, R. A. (1998). The elusive nature of intrinsic efficacy. Trends Pharmacol. Sci. 19, 270-276.
8. Colquhoun, D. (1973). The relationship between classical and cooperative models for drug action. In: Drug Receptors. A Symposium (Rang, H. P., ed.) pp. 149-182. Baltimore: University Park Press.
9. Colquhoun, D. (1987). Affinity, efficacy, and receptor classification: Is the classical theory still useful? In: Perspectives on Receptor Classification (Black, J. W., Jenkinson, D. H. & Gerskowitch, V. P., eds) pp. 103-114. New York: Alan R. Liss.
10. Furchgott, R. F. (1966). The use of β-haloalkylamines in teh differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In: Advances in Drug Research (Harper, N. J. & Simmonds, A. B., eds) pp. 25-55. London: Academic Press.
11. Gilman, A. G. (1987). G proteins: Transducers of receptor-generated signals. Ann. Rev. Biochem. 56, 615-649.
12. Jenkinson, D. H. (1989). Finding affinity constants for agonists by the irreversible antagonist method. Trends Pharmacol. Sci. 10, 16-17.
13. Kenakin, T. (1984). The classification of drugs and drug responses in isolated tissues. Pharmacol. Rev. 36, 165-222.
14. Kenakin, T. (1993). Pharmacologic Analysis of Drug-Receptor Interaction 2nd Edn. New York: Raven Press.
15. Kenakin, T. (1996). The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48, 413-463.
16. Kenakin, T. (1997). Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol. Sci. 18, 456-464.
17. Lamb, T. D. & Pugh, E. N. Jr. (1992). G-protein cascades: Gain and kinetics. Trends Neurosci. 15, 291-297.
18. Leff, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci. 16, 89-97.
19. Leff, P. & Harper, D. (1989). Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates? J. Theor. Biol. 140, 381-397.
20. Leff, P., Dougall, I. G. & Harper, D. (1993). Estimation of partial agonist affinity by interaction with a full agonist: A direct operational model-fitting approach. Br. J. Pharmacol. 110, 239-244.
21. Leff, P., Prentice, D. J., Giles, H., Martin, G. R. & Wood, J. (1990). Estimation of agonist affinity and efficacy by direct, operational model-fitting. J. Pharmacol. Meth. 23, 225-237.
22. Leff, P., Scaramellini, C., Law, C. & McKechnie, K. (1997). A three-state receptor model of agonist action. Trends Pharmacol. Sci. 18, 355-362.
23. Mackay, D. (1966). The mathematics of drug-receptor interactions. J. Pharm. Pharmacol. 18, 201-222.
24. Mackay, D. (1977). A critical survey of receptor theories of drug action. In: Kinetics of Drug Action (Van Rossum, J. M., ed.) pp. 255-321. New York: Springer-Verlag.
25. Mackay, D. (1987). Use of null equations, based on classical and ternary models of drug actio, to classify receptors and receptor-effector systems even if some of the agonists and antagonists have additional actions on the tissues. In: Perspectives on Receptor Classification (Black, J. W., Jenkinson, D. H. & Gerskowitch, V. P., eds) pp. 193-206. New York: Alan R. Liss.
26. Mackay, D. (1988). Continuous variation of agonist affinity constants. Trends Pharmacol. Sci. 9, 156-157.
27. Mackay, D. (1990). Interpretation of relative potencies, relative efficacies and apparent affinity constants of agonist drugs estimated from concentration-response curves. J. Theor. Biol. 142, 415-427.
28. Mahama, P. A. & Linderman, J. J. (1994). A Monte Carlo study of the dynamics of G-protein activation. Biophys. J. 67, 1345-1357.
29. RAX as parameter for classification. Trends Pharmacol. Sci. 9, 351.
30. Ruffolo, R. R. Jr. (1982). Important concepts of receptor theory. J. Autonom. Pharmacol. 209, 429-436.
31. Shelley, D. E., Sim, L. J., Xiao, R., Liu, Q. & Childers, S. R. (1997). μ-opioid receptor-stimulated guanosine-5′-O′(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. J. Pharmacol. Exp. Ther. 51, 87-96.
32. Shea, L. & Linderman, J. J. (1997). Mechanistic model of G-protein signal transduction. Biochem. Pharmacol. 53, 519-530.
33. Shea, L. D. & Linderman, J. J. (1998). Compartmentalization of receptors and enzymes affects activation for a collision coupling mechanism. J. Theor. Biol. 191, 249-258.
34. Stephenson, R. P. (1956). A modification of receptor theory. Br. J. Pharmacol. 11, 379-393.
35. Stickle, D. & Barber, R. (1989). Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Mol. Pharmacol. 36, 437-445.
36. Stickle, D. & Barber, R. (1991). Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase. Mol. Pharmacol. 40, 276-288.
37. Tallarida, R. J. (1988). Pharmacologic methods for identification of receptors. Life Sci. 43, 2169-2176.
38. Tallarida, R. J. (1995). Receptor discrimination and control of agonist-antagonist binding. Am. J. Physiol. 269, E379-E391.
39. 2-adrenergic receptor. Mol. Pharmacol. 34, 814-822.
40. Thron, C. D. (1973). On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol. 9, 1-9.
41. Trahey, M. & McCormick, F. (1987). A cytoplasmic protein stimulates normal N-ras p21 GTPase. Science 238, 542-544.
42. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. J. Pharmacol. Exp. Ther. 47, 848-854.
43. z GAP and other RGS proteins by palmitoylation of G protein α subunits. Science 278, 1132-1135.
44. Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. (1996a). The cubic ternary complex receptor-occupancy model I. Model description. J. Theor. Biol. 178, 151-167.
45. Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. (1996b). The cubic ternary complex receptor-occupancy model II. Understanding apparent affinity. J. Theor. Biol. 178, 169-182.
46. Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. (1996c). The cubic ternary complex receptor-occupancy model III. Resurrecting efficacy. J. Theor. Biol. 181, 381-397.